Summary & Overview
HCPCS Level II M1421: Dermatology MIPS Value Pathway
HCPCS Level II code M1421 designates dermatological services tied to a MIPS value pathway, signaling billing for care and reporting activities within dermatology-focused quality and performance programs. Nationally, codes that map to value pathways are important for aligning clinical practice with incentive structures and quality measurement under federal programs and major commercial payers. Coverage decisions and claims processing for M1421 can affect provider reporting workflows and revenue cycle operations.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage context, common modifiers used in practice, and implications for outpatient dermatology clinics that participate in MIPS or other value-based arrangements.
Readers will find benchmarks and reporting guidance relevant to billing and coding for value-pathway dermatology services, a summary of common modifiers in claims practice, and clinical context for how the code ties to outpatient dermatology care delivery. The piece also flags areas where input data was not provided and notes where organizations should reference payer-specific policy for coverage details.
Billing Code Overview
HCPCS Level II code M1421 represents Dermatological care MIPS value pathway services. This code is used to denote services aligned with a value pathway for dermatology within the Merit-based Incentive Payment System (MIPS), focusing on measures and care delivery tied to dermatologic practice improvement and quality reporting.
Service type: Dermatology value-based care pathway
Typical site of service: Outpatient dermatology settings, including dermatology clinics and ambulatory care centers.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with a history of chronic plaque psoriasis and multiple prior dermatologic interventions presents to a dermatology clinic participating in a MIPS Value Pathway focused on dermatological care (M1421). The patient reports progressive plaque thickening and new areas of involvement causing pruritus and impaired quality of life. The clinical workflow includes intake by medical assistants, standardized collection of patient-reported outcomes and lesion photographs, evaluation by a board-certified dermatologist, formulation of an evidence-based treatment plan (topical therapy, phototherapy, or systemic biologic therapy), documentation of shared decision-making, and care coordination with primary care for comorbidity management.
During the visit the dermatologist performs a focused skin exam, documents lesion distribution and severity scores (for example, body surface area and Physician Global Assessment), orders baseline laboratory testing if systemic therapy is considered, provides counseling on side effects and monitoring, and schedules follow-up. If a procedure such as lesion biopsy, cryotherapy, or injection is medically indicated, that service is performed or arranged. The visit documentation supports quality reporting under the MIPS dermatology value pathway, including appropriate diagnostic coding, use of relevant CPT and HCPCS codes, and application of any modifiers reflecting unusual circumstances or multiple providers involved in care. Typical sites of service include outpatient dermatology clinics, ambulatory surgical centers for procedures, and hospital-based dermatology clinics when consultative or procedural care is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|